AMERISAFE(AMSF)
Search documents
AMERISAFE(AMSF) - 2021 Q3 - Earnings Call Transcript
2021-10-30 04:00
AMERISAFE, Inc. (NASDAQ:AMSF) Q3 2021 Earnings Conference Call October 28, 2021 10:30 AM ET Company Participants Kathryn Shirley - Chief Administrative Officer Janelle Frost - President and CEO Neal Fuller - CFO Conference Call Participants Mark Hughes - Truist Matt Carletti - JMP Operator Good day, and welcome to the AMERISAFE 2021 Third Quarter Earnings Conference Call. [Operator Instructions] At this time, I'd like to turn the conference over to Kathryn Shirley, Chief Administrative Officer. Please go ah ...
AMERISAFE(AMSF) - 2021 Q3 - Quarterly Report
2021-10-28 16:00
Financial Performance - Gross premiums written for Q3 2021 were $67.185 million, a decrease of 7.4% from $72.648 million in Q3 2020[16] - Net premiums earned for the nine months ended September 30, 2021, were $208.260 million, down 9.4% from $229.725 million for the same period in 2020[16] - Total revenues for Q3 2021 were $73.045 million, a decrease of 12.0% from $83.005 million in Q3 2020[16] - Net income for Q3 2021 was $19.136 million, down 18.5% from $23.353 million in Q3 2020[16] - Earnings per share for Q3 2021 were $0.99, compared to $1.21 for Q3 2020, reflecting a decrease of 18.5%[16] - Net income for the nine months ended September 30, 2021, was $62,215, compared to $58,101 for the same period in 2020, reflecting an increase of about 3.6%[24] - The company reported comprehensive income of $56,182 for the nine months ended September 30, 2021, down from $65,802 in the same period of 2020, indicating a decrease of approximately 14.9%[24] - The net combined ratio for Q3 2021 was 71.5%, improving from 72.8% in Q3 2020[108] - The net loss ratio was 48.8% in the first nine months of 2021, down from 52.7% for the same period in 2020[122] Investment Income - Net investment income for Q3 2021 was $6.049 million, a decline of 14.4% compared to $7.063 million in Q3 2020[16] - The pre-tax investment yield on the investment portfolio for Q3 2021 was 2.1% per annum, down from 2.3% per annum in Q3 2020[111] - The company reported net cash provided by investing activities of $48.904 million for the nine months ended September 30, 2021, a significant increase from $9.406 million in the same period of 2020[26] Shareholder Equity and Dividends - Shareholders' equity increased to $480.156 million as of September 30, 2021, compared to $438.816 million at the end of 2020[13] - Cash dividends declared per common share increased to $0.29 in Q3 2021 from $0.27 in Q3 2020[16] - Dividends to shareholders for the nine months ended September 30, 2021, amounted to $16,837, an increase from $15,650 in the same period of 2020, representing an increase of approximately 7.6%[24] Assets and Reserves - Total assets as of September 30, 2021, were $1.479 billion, a slight increase from $1.471 billion at the end of 2020[11] - Reserves for loss and loss adjustment expenses decreased to $720.789 million from $760.561 million year-over-year[12] - The net balance for unpaid loss and loss adjustment expenses at the end of the period was $720.8 million, a decrease from $759.9 million at the end of September 30, 2020[71] Share Repurchase Program - The company has not repurchased any shares under its share repurchase program in the nine months ended September 30, 2021, maintaining the limit of $25.0 million[97] - No shares were repurchased during the three months ended September 30, 2021 and 2020, indicating a pause in the buyback program[146] - As of September 30, 2021, the company repurchased a total of 1,258,250 shares for $22.4 million, with $25.0 million available for future purchases[146] Cash and Cash Equivalents - Total cash and cash equivalents at the end of the period increased to $123.128 million from $88.168 million year-over-year, marking a growth of 39.7%[26] - As of September 30, 2021, total cash and cash equivalents were reported at $123,128,000, compared to $61,757,000 as of December 31, 2020, an increase of 99%[96] Other Financial Metrics - The company recorded a provision for credit loss benefit of $60,000 for the three months ended September 30, 2021, compared to a benefit of $9,000 for the same period in 2020[74] - The company experienced favorable development of net reserves, reducing loss and loss adjustment expenses incurred by $48.3 million in 2021[71] - The company recorded favorable prior accident year development of $48.3 million in the first nine months of 2021, compared to $45.6 million in the same period of 2020[133]
AMERISAFE(AMSF) - 2021 Q2 - Earnings Call Transcript
2021-07-31 18:03
Financial Data and Key Metrics Changes - AMERISAFE reported net income of $23.8 million or $1.23 per diluted share, compared to $23.9 million or $1.24 per diluted share in the same quarter last year [11] - Operating net income increased to $20.2 million or $1.04 per share, an increase of $0.04 from the second quarter of 2020 [11] - Revenues decreased to $81.2 million from $89.1 million in the second quarter of 2020 [11] - Net premiums earned decreased by 8% to $69.9 million compared to the previous year [11] - Total underwriting and other expenses were $18.5 million, down from $21.1 million in the second quarter of 2020, leading to an expense ratio of 26.4% compared to 27.8% last year [14] Business Line Data and Key Metrics Changes - The combined ratio for the quarter was 74.4%, attributed to favorable case development from accident years 2019 and prior [6] - Policy count remained flat, with premium for policies written down 8.9% and average loss cost down 6.5% [7] - Renewal retention was strong at 93.9%, compared to 93.7% in the same quarter last year [31] Market Data and Key Metrics Changes - The workers' compensation market saw no substantial changes, with approved loss cost decreases averaging in mid-single digits [6] - Audit premium remained positive despite the full impact of the COVID-19 pandemic on the audited policy period [7] - Frequency for the current accident year returned to pre-pandemic levels, while severity remained within expectations [9] Company Strategy and Development Direction - The company is focused on maintaining competitiveness and discipline in underwriting, with a long-term approach to underwriting discipline and claims management [6] - Management remains optimistic about the potential benefits from the infrastructure bill, which includes significant funding for roads, bridges, and broadband [19] - The company aims to manage capital towards a target operating leverage ratio of 1.1x, currently at 0.62x [15] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the vaccination rollout and its potential positive impact on the economy, despite concerns about the Delta variant [20] - The company noted that while there are delays in the supply chain, capital expenditures are ready to be funded [30] - Management acknowledged the potential for wage inflation, with a payroll increase of about 2.9%, primarily driven by wage inflation [29] Other Important Information - The investment portfolio has a high quality with an average AA minus credit rating and a duration of 3.67 [13] - The company paid a quarterly cash dividend of $0.29 per share, consistent with previous quarters [15] - Book value per share increased to $24.19, up 6.6% from $22.70 at year-end [15] Q&A Session Summary Question: Did you give the ELCM? - Janelle Frost confirmed the ELCM was 1.52 [17] Question: Can you talk about the prospects for new business? - Management remains optimistic about the economy due to vaccination rollouts and potential benefits from the infrastructure bill, although policy count did not grow in the second quarter [19][21] Question: Was this the first quarter that you drew from the 2019 accident year? - Yes, it was the first quarter that drew from 2019, with reported numbers showing deterioration in the workers' compensation industry [23][24] Question: How is renewal premium impacted by wage inflation? - Management noted a payroll increase of about 2.9%, with 80% attributed to wage inflation, and renewal retention remained strong [29][31] Question: How do you see the supply chain affecting future jobs? - Management is monitoring the supply chain closely, noting potential delays but also increased flow from the lumber industry [30]
AMERISAFE(AMSF) - 2021 Q2 - Quarterly Report
2021-07-29 16:00
```markdown [FORWARD-LOOKING STATEMENTS](index=3&type=section&id=FORWARD-LOOKING%20STATEMENTS) This section highlights that the report contains forward-looking statements subject to various risks and uncertainties inherent in the business and insurance industry - The report contains forward-looking statements that reflect current management views on financial performance and future events in the business and insurance industry, which involve risks and uncertainties[9](index=9&type=chunk) - Key risk factors that could cause actual results to differ materially include the cyclical nature of the workers' compensation insurance industry, impact of pandemics, increased competition, changes in relationships with independent agencies, general economic conditions, developments in capital markets, technology breaches, decreased business activity of policyholders, greater frequency or severity of claims, adverse regulatory conditions, loss of key employees, changes in regulations/laws/taxes, changes in accounting standards, changes in legal theories of liability, changes in rating agency policies, and changes in reinsurance availability/cost/quality[9](index=9&type=chunk) [PART I - FINANCIAL INFORMATION](index=4&type=section&id=PART%20I%20-%20FINANCIAL%20INFORMATION) This section presents the company's unaudited consolidated financial statements and management's discussion and analysis of financial condition and results of operations [Item 1. Financial Statements](index=4&type=section&id=Item%201%20Financial%20Statements) This section presents the unaudited consolidated financial statements of AMERISAFE, Inc. and its subsidiaries, including balance sheets, statements of income, comprehensive income, changes in shareholders' equity, and cash flows, along with detailed notes explaining the basis of presentation, accounting policies, and specific financial line items [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) This section presents the company's financial position at specific dates, detailing assets, liabilities, and shareholders' equity Consolidated Balance Sheet Data (in thousands) | Metric (in thousands) | June 30, 2021 | December 31, 2020 | | :-------------------- | :------------ | :---------------- | | Total Assets | $1,506,263 | $1,470,855 | | Total Liabilities | $1,037,897 | $1,032,039 | | Total Shareholders' Equity | $468,366 | $438,816 | [Consolidated Statements of Income](index=5&type=section&id=Consolidated%20Statements%20of%20Income) This section details the company's financial performance over specific periods, including revenues, expenses, and net income Consolidated Income Statement Data (in thousands, except per share) | Metric (in thousands, except per share) | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Net Premiums Earned | $69,888 | $75,964 | $140,634 | $154,954 | | Total Revenues | $81,157 | $89,082 | $164,508 | $168,251 | | Total Expenses | $51,986 | $59,691 | $111,712 | $125,619 | | Net Income | $23,767 | $23,948 | $43,079 | $34,748 | | Basic EPS | $1.23 | $1.24 | $2.23 | $1.80 | | Diluted EPS | $1.23 | $1.24 | $2.22 | $1.80 | | Cash Dividends Declared per Common Share | $0.29 | $0.27 | $0.58 | $0.54 | [Consolidated Statements of Comprehensive Income](index=6&type=section&id=Consolidated%20Statements%20of%20Comprehensive%20Income) This section presents the company's comprehensive income, which includes net income and other comprehensive income items Consolidated Comprehensive Income Data (in thousands) | Metric (in thousands) | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Net Income | $23,767 | $23,948 | $43,079 | $34,748 | | Unrealized gain (loss) on debt securities, net of tax | $891 | $5,483 | $(4,157) | $6,967 | | Comprehensive Income | $24,658 | $29,431 | $38,922 | $41,715 | [Consolidated Statements of Changes in Shareholders' Equity](index=7&type=section&id=Consolidated%20Statements%20of%20Changes%20in%20Shareholders'%20Equity) This section outlines changes in the company's shareholders' equity over time, reflecting net income, dividends, and other adjustments - Total shareholders' equity increased from **$438,816 thousand** at December 31, 2020, to **$468,366 thousand** at June 30, 2021, primarily due to net income of **$43,079 thousand**, partially offset by dividends to shareholders of **$11,221 thousand** and a decrease in accumulated other comprehensive income[26](index=26&type=chunk) [Consolidated Statements of Cash Flows](index=9&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) This section reports the cash inflows and outflows from operating, investing, and financing activities over specific periods Consolidated Cash Flow Data (in thousands) | Cash Flow Activity (in thousands) | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------------------- | :----------------------------- | :----------------------------- | | Net cash provided by operating activities | $25,994 | $42,170 | | Net cash provided by (used in) investing activities | $(18,878) | $34,835 | | Net cash used in financing activities | $(11,332) | $(10,537) | | Change in cash and cash equivalents | $(4,216) | $66,468 | | Cash and cash equivalents at end of period | $57,541 | $110,281 | [Note 1. Basis of Presentation](index=10&type=section&id=Note%201.%20Basis%20of%20Presentation) AMERISAFE, Inc. is an insurance holding company providing workers' compensation insurance for small to mid-sized employers in hazardous industries. The consolidated financial statements include AMERISAFE and its subsidiaries, prepared in accordance with Form 10-Q and GAAP, with management estimates and assumptions - AMERISAFE provides workers' compensation insurance for small to mid-sized employers in hazardous industries such as construction, trucking, logging and lumber, manufacturing, agriculture, maritime, and oil and gas[32](index=32&type=chunk) - The unaudited consolidated financial statements are prepared in accordance with Form 10-Q and GAAP, relying on management's estimates and assumptions[33](index=33&type=chunk)[34](index=34&type=chunk) [Note 2. Restricted Stock and Stock Options](index=10&type=section&id=Note%202.%20Restricted%20Stock%20and%20Stock%20Options) The Company operates two equity incentive plans: the Non-Employee Director Restricted Stock Plan and the 2012 Equity and Incentive Compensation Plan. During the first six months of 2021, 32,995 shares of common stock were issued, and share-based compensation expense decreased compared to the prior year Restricted Stock and Stock Option Data (in thousands) | Metric (in thousands) | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------- | :----------------------------- | :----------------------------- | | Shares of common stock issued | 32,995 | 28,476 | | Market value of shares issued | $2.2 million | $1.8 million | | Share-based compensation expense | $1.3 million | $1.8 million | [Note 3. Earnings Per Share](index=11&type=section&id=Note%203.%20Earnings%20Per%20Share) The Company calculates Basic and Diluted Earnings Per Share (EPS) in accordance with FASB ASC Topic 260, using the treasury stock method for potential common shares Earnings Per Share Data | Metric | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :----- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Basic EPS | $1.23 | $1.24 | $2.23 | $1.80 | | Diluted EPS | $1.23 | $1.24 | $2.22 | $1.80 | [Note 4. Investments](index=11&type=section&id=Note%204.%20Investments) The Company's investment portfolio includes held-to-maturity, available-for-sale, and equity securities. Net realized gains on investments increased for both the three and six months ended June 30, 2021, primarily from sales of available-for-sale fixed maturity securities. Net unrealized gains on equity securities significantly improved for the six-month period Investment Portfolio Fair Value (in thousands) | Investment Type (in thousands) | June 30, 2021 Fair Value | December 31, 2020 Fair Value | | :----------------------------- | :----------------------- | :--------------------------- | | Fixed maturity securities—held-to-maturity | $589,601 | $621,654 | | Fixed maturity securities—available-for-sale | $369,890 | $414,279 | | Equity securities | $55,375 | $43,437 | | Short-term investments | $129,109 | $45,898 | | Total Investments | $1,112,805 | $1,088,744 | Investment Gains and Losses (in thousands) | Metric (in thousands) | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Net Realized Gains on Investments | $1,179 | $163 | $1,498 | $1,155 | | Net Unrealized Gains (Losses) on Equity Securities | $3,286 | $5,570 | $8,797 | $(3,193) | - The allowance for credit losses on held-to-maturity securities decreased from **$274 thousand** at December 31, 2020, to **$157 thousand** at June 30, 2021, primarily due to a provision for credit loss benefit of **$117 thousand** for the six months ended June 30, 2021[63](index=63&type=chunk) [Note 5. Income Taxes](index=16&type=section&id=Note%205.%20Income%20Taxes) The Company maintains a valuation allowance against its deferred income tax benefits and reports income tax expense based on a 21% statutory rate, adjusted for tax-exempt investment income and state income tax accruals Income Tax Valuation Allowance (in millions) | Metric (in millions) | June 30, 2021 | June 30, 2020 | | :------------------- | :------------ | :------------ | | Valuation allowance against deferred income tax benefits | $1.3 | $1.9 | - Income tax expense differs from the **21%** U.S. federal statutory rate primarily due to tax-exempt investment income and state income tax accruals[70](index=70&type=chunk) [Note 6. Loss Reserves](index=16&type=section&id=Note%206.%20Loss%20Reserves) The Company records reserves for estimated losses and loss adjustment expenses, which are continually reviewed and adjusted. Favorable development in prior accident year net reserves reduced loss and loss adjustment expenses incurred for both the six months ended June 30, 2021 and 2020 Loss and Loss Adjustment Expense Reserves (in thousands) | Metric (in thousands) | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------- | :----------------------------- | :----------------------------- | | Balance, beginning of period (Loss and LAE) | $760,561 | $772,887 | | Net balance, end of period (Loss and LAE) | $634,194 | $666,789 | | Favorable prior accident year development | $29,317 | $31,165 | Allowance for Credit Losses on Reinsurers (in thousands) | Metric (in thousands) | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Allowance for credit losses on amounts recoverable from reinsurers, end of period | $449 | $388 | $449 | $388 | [Note 7. Comprehensive Income and Accumulated Other Comprehensive Income](index=17&type=section&id=Note%207.%20Comprehensive%20Income%20and%20Accumulated%20Other%20Comprehensive%20Income) Comprehensive income includes net income plus unrealized gains (losses) on available-for-sale investment securities, net of tax. The difference between net income and comprehensive income is primarily due to changes in unrealized gains and losses on available-for-sale debt securities Comprehensive Income and AOCI Data (in thousands) | Metric (in thousands) | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Comprehensive Income | $24,658 | $29,431 | $38,922 | $41,715 | | Balance, Accumulated Other Comprehensive Income, end of period | $16,862 | $19,178 | $16,862 | $19,178 | - Reclassifications from accumulated other comprehensive income to net income primarily relate to unrealized gains on available-for-sale securities, totaling **$1,248 thousand** for the three months ended June 30, 2021, and **$1,561 thousand** for the six months ended June 30, 2021[82](index=82&type=chunk) [Note 8. Fair Value Measurements](index=18&type=section&id=Note%208.%20Fair%20Value%20Measurements) The Company measures financial instruments at fair value using a hierarchy of inputs (Level 1, 2, and 3) to maximize observable inputs. Equity and treasury securities are Level 1, while most fixed maturity securities and short-term investments are Level 2 - Fair value is determined based on quoted market prices or internally developed models using observable market-based parameters, prioritizing Level 1 (quoted prices in active markets) and Level 2 (observable inputs other than quoted prices) inputs[88](index=88&type=chunk)[89](index=89&type=chunk) Fair Value Hierarchy of Financial Instruments (in thousands) | Financial Instrument (in thousands) | Level 1 Inputs | Level 2 Inputs | Level 3 Inputs | Total Fair Value | | :---------------------------------- | :------------- | :------------- | :------------- | :--------------- | | Securities available-for-sale—fixed maturity | $29,192 | $340,698 | $— | $369,890 | | Equity securities | $55,375 | $— | $— | $55,375 | | Total (June 30, 2021) | $84,567 | $340,698 | $— | $425,265 | Carrying Amount vs. Fair Value of Financial Instruments (in thousands) | Financial Instrument (in thousands) | June 30, 2021 Carrying Amount | June 30, 2021 Fair Value | December 31, 2020 Carrying Amount | December 31, 2020 Fair Value | | :---------------------------------- | :---------------------------- | :----------------------- | :-------------------------------- | :--------------------------- | | Fixed maturity securities—held-to-maturity | $558,431 | $589,601 | $585,130 | $621,654 | | Fixed maturity securities—available-for-sale | $369,890 | $369,890 | $414,279 | $414,279 | | Equity securities | $55,375 | $55,375 | $43,437 | $43,437 | | Short-term investments | $129,109 | $129,109 | $45,898 | $45,898 | | Cash and cash equivalents | $57,541 | $57,541 | $61,757 | $61,757 | [Note 9. Treasury Stock](index=21&type=section&id=Note%209.%20Treasury%20Stock) The Company has a share repurchase program authorized by its Board of Directors. As of June 30, 2021, no shares were repurchased during the current quarter or the prior year's comparable period - The Board reauthorized a share repurchase program in October 2016 with a limit of **$25.0 million** and no expiration date[100](index=100&type=chunk) - As of June 30, 2021, the Company had repurchased **1,258,250 shares** for **$22.4 million**, with **$25.0 million** remaining available for future purchases[145](index=145&type=chunk) - No shares were repurchased under this program during the three months ended June 30, 2021 and 2020[100](index=100&type=chunk)[145](index=145&type=chunk) [Note 10. Subsequent Events](index=21&type=section&id=Note%2010.%20Subsequent%20Events) On July 27, 2021, the Board of Directors declared a quarterly cash dividend of $0.29 per share, payable on September 24, 2021 - A quarterly cash dividend of **$0.29 per share** was declared on July 27, 2021, payable on September 24, 2021[101](index=101&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=22&type=section&id=Item%202%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section provides management's perspective on AMERISAFE's financial condition and results of operations, covering business overview, critical accounting policies, detailed analysis of revenues and expenses for the three and six months ended June 30, 2021 and 2020, liquidity, capital resources, investment portfolio, and prior year development [Business Overview](index=22&type=section&id=Business%20Overview) AMERISAFE is an insurance holding company specializing in workers' compensation insurance for small to mid-sized employers in hazardous industries. Its strategy focuses on disciplined underwriting, proactive safety reviews, intensive claims management, and audit services to achieve attractive returns - AMERISAFE targets small to mid-sized employers in hazardous industries (e.g., construction, trucking, logging, manufacturing, agriculture, maritime, oil and gas) due to higher premium rates and less frequent but more severe claims[104](index=104&type=chunk) - The company's strategy includes proactive safety reviews, intensive claims management, and audit services to reduce overall claim costs and ensure appropriate premiums[104](index=104&type=chunk) - AMERISAFE actively markets insurance in **27 states** through independent agencies and its wholly owned insurance agency subsidiary, and is licensed in an additional **20 states**, DC, and the U.S. Virgin Islands[104](index=104&type=chunk) [Critical Accounting Policies](index=22&type=section&id=Critical%20Accounting%20Policies) Management identifies several critical accounting policies that require significant estimates and assumptions, which are crucial for understanding the financial statements and may lead to differences between estimates and actual future results - Critical accounting policies include reserves for loss and loss adjustment expenses, amounts recoverable from reinsurers, premiums receivable, assessments, deferred policy acquisition costs, deferred income taxes, credit losses on investment securities, and share-based compensation[106](index=106&type=chunk) - These policies involve significant estimates and assumptions that can be subjective and complex, potentially causing actual results to differ from estimates in future periods[105](index=105&type=chunk) [Results of Operations](index=23&type=section&id=Results%20of%20Operations) The Company experienced a decrease in gross and net premiums written and earned for both the three and six months ended June 30, 2021, compared to 2020. Net investment income also declined due to lower yields. However, net income increased for the six-month period, driven by higher net unrealized gains on equity securities and favorable prior accident year development [Consolidated Results of Operations for Three Months Ended June 30, 2021 Compared to June 30, 2020](index=23&type=section&id=Consolidated%20Results%20of%20Operations%20for%20Three%20Months%20Ended%20June%2030,%202021%20Compared%20to%20June%2030,%202020) This section analyzes the company's financial performance for the three months ended June 30, 2021, compared to the same period in 2020 Three Months Ended June 30, 2021 vs. 2020 Financial Performance (in thousands, except ratios) | Metric (in thousands) | Q2 2021 | Q2 2020 | Change ($) | Change (%) | | :-------------------- | :----------- | :----------- | :----------- | :----------- | | Gross Premiums Written | $73,724 | $80,289 | $(6,565) | -8.2% | | Net Premiums Written | $71,238 | $77,617 | $(6,379) | -8.2% | | Net Premiums Earned | $69,888 | $75,964 | $(6,076) | -8.0% | | Net Investment Income | $6,730 | $7,324 | $(594) | -8.1% | | Net Realized Gains on Investments | $1,179 | $163 | $1,016 | 623.3% | | Net Unrealized Gains on Equity Securities | $3,286 | $5,570 | $(2,284) | -41.0% | | Loss and LAE Incurred | $32,423 | $37,530 | $(5,107) | -13.6% | | Underwriting and Certain Other Operating Costs, Commissions and Salaries and Benefits | $18,500 | $21,131 | $(2,631) | -12.4% | | Income Tax Expense | $5,404 | $5,443 | $(39) | -0.7% | | Net Income | $23,767 | $23,948 | $(181) | -0.8% | | Diluted EPS | $1.23 | $1.24 | $(0.01) | -0.8% | | Net Combined Ratio | 74.4% | 78.5% | -4.1 pp | | | Return on Average Equity | 20.8% | 21.3% | -0.5 pp | | [Consolidated Results of Operations for Six Months Ended June 30, 2021 Compared to June 30, 2020](index=24&type=section&id=Consolidated%20Results%20of%20Operations%20for%20Six%20Months%20Ended%20June%2030,%202021%20Compared%20to%20June%2030,%202020) This section analyzes the company's financial performance for the six months ended June 30, 2021, compared to the same period in 2020 Six Months Ended June 30, 2021 vs. 2020 Financial Performance (in thousands, except ratios) | Metric (in thousands) | H1 2021 | H1 2020 | Change ($) | Change (%) | | :-------------------- | :----------- | :----------- | :----------- | :----------- | | Gross Premiums Written | $155,238 | $167,360 | $(12,122) | -7.2% | | Net Premiums Written | $150,235 | $161,905 | $(11,670) | -7.2% | | Net Premiums Earned | $140,634 | $154,954 | $(14,320) | -9.2% | | Net Investment Income | $13,313 | $15,073 | $(1,760) | -11.7% | | Net Realized Gains on Investments | $1,498 | $1,155 | $343 | 29.7% | | Net Unrealized Gains (Losses) on Equity Securities | $8,797 | $(3,193) | $11,990 | N/A | | Loss and LAE Incurred | $71,940 | $81,177 | $(9,237) | -11.4% | | Underwriting and Certain Other Operating Costs, Commissions and Salaries and Benefits | $37,442 | $42,415 | $(4,973) | -11.7% | | Income Tax Expense | $9,717 | $7,884 | $1,833 | 23.2% | | Net Income | $43,079 | $34,748 | $8,331 | 24.0% | | Diluted EPS | $2.22 | $1.80 | $0.42 | 23.3% | | Net Combined Ratio | 79.6% | 81.1% | -1.5 pp | | | Return on Average Equity | 19.0% | 15.6% | +3.4 pp | | Key Financial Measures | Key Measure | June 30, 2021 | June 30, 2020 | | :---------- | :------------ | :------------ | | Net Combined Ratio | 74.4% (Q2) / 79.6% (H1) | 78.5% (Q2) / 81.1% (H1) | | Return on Average Equity | 20.8% (Q2) / 19.0% (H1) | 21.3% (Q2) / 15.6% (H1) | | Book Value per Share | $24.19 | $23.94 | [Liquidity and Capital Resources](index=25&type=section&id=Liquidity%20and%20Capital%20Resources) The Company's primary operating funds come from premiums, investment income, and investment sales. Net cash provided by operating activities decreased for the six months ended June 30, 2021, while investing activities shifted from providing to using cash, and financing activities used slightly more cash due to increased dividends - Principal sources of operating funds are premiums, investment income, and proceeds from investment sales and maturities; primary uses are claims payments and operating expenses[125](index=125&type=chunk) Cash Flow Summary (in thousands) | Cash Flow Activity (in thousands) | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :-------------------------------- | :----------------------------- | :----------------------------- | | Net cash provided by operating activities | $25,994 | $42,170 | | Net cash used in investing activities | $(18,878) | $34,835 (provided) | | Net cash used in financing activities | $(11,332) | $(10,537) | - The decrease in operating cash flow was due to increased amounts held by others, higher federal taxes paid, decreased premium collections, and lower investment income, partially offset by reduced underwriting expenses and losses paid[125](index=125&type=chunk) [Investment Portfolio](index=26&type=section&id=Investment%20Portfolio) The investment portfolio, totaling $1.2 billion, is composed of held-to-maturity, available-for-sale, equity, short-term investments, and cash. Held-to-maturity securities are recorded at amortized cost, while available-for-sale and equity securities are reported at fair value, with unrealized gains/losses on available-for-sale debt securities recorded to Accumulated Other Comprehensive Income - The total investment portfolio, including cash and cash equivalents, was **$1.2 billion** at June 30, 2021, consistent with December 31, 2020[129](index=129&type=chunk) Investment Portfolio Composition (in thousands) | Investment Type | Carrying Amount (in thousands) | Percentage of Portfolio | | :------------------------------------------------- | :----------------------------- | :---------------------- | | Fixed maturity securities—held-to-maturity | $558,431 | 47.8% | | Fixed maturity securities—available-for-sale | $369,890 | 31.6% | | Equity securities | $55,375 | 4.7% | | Short-term investments | $129,109 | 11.0% | | Cash and cash equivalents | $57,541 | 4.9% | | Total investments, including cash and cash equivalents | $1,170,346 | 100.0% | - Debt securities classified as available-for-sale are marked to market, with non-credit related unrealized gains and losses recorded to Accumulated Other Comprehensive Income. Held-to-maturity debt securities require an allowance for expected credit losses recognized through earnings[131](index=131&type=chunk)[132](index=132&type=chunk) [Prior Year Development](index=27&type=section&id=Prior%20Year%20Development) The Company recorded favorable prior accident year development for both the three and six months ended June 30, 2021, primarily due to favorable case reserve development from closed claims and claims where workers reached maximum medical improvement. The number of open claims decreased compared to the prior year Net Prior Accident Year Development (in millions) | Metric (in millions) | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Total net development | $17.9 | $17.5 | $29.3 | $31.2 | Claims Activity Data | Claims Data | Three Months Ended June 30, 2021 | Three Months Ended June 30, 2020 | Six Months Ended June 30, 2021 | Six Months Ended June 30, 2020 | | :---------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Open claims at beginning of period | 4,607 | 4,910 | 4,758 | 5,053 | | Claims reported | 1,078 | 1,004 | 2,127 | 2,106 | | Claims closed | (1,112) | (1,293) | (2,312) | (2,538) | | Open claims at end of period | 4,573 | 4,621 | 4,573 | 4,621 | - Favorable loss development was largely due to favorable case reserve development from closed claims and claims where the worker had reached maximum medical improvement[135](index=135&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=28&type=section&id=Item%203%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The Company's market risk primarily stems from credit risk, interest rate risk, and equity price risk. There have been no material changes to its market risk profile since December 31, 2020 - Major components of market risk affecting the Company are credit risk, interest rate risk, and equity price risk[139](index=139&type=chunk) - There have been no material changes in the quantitative or qualitative aspects of the Company's market risk profile since December 31, 2020[139](index=139&type=chunk) [Item 4. Controls and Procedures](index=28&type=section&id=Item%204%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that the Company's disclosure controls and procedures were effective as of June 30, 2021, providing reasonable assurance for timely and accurate reporting. No material changes in internal control over financial reporting occurred during the period - The Chief Executive Officer and Chief Financial Officer concluded that the Company's disclosure controls and procedures were effective as of June 30, 2021, to provide reasonable assurance that required information is recorded, processed, summarized, and reported timely[140](index=140&type=chunk) - No changes in internal control over financial reporting materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting during the period[142](index=142&type=chunk) [PART II - OTHER INFORMATION](index=29&type=section&id=PART%20II%20-%20OTHER%20INFORMATION) This section covers other required information, including unregistered sales of equity securities and a list of exhibits [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=29&type=section&id=Item%202%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details the Company's share repurchase program, which had $25.0 million available for future purchases as of June 30, 2021. No shares were repurchased during the three months ended June 30, 2021 and 2020 - The Board of Directors reauthorized a share repurchase program in October 2016 with no expiration date[145](index=145&type=chunk) - As of June 30, 2021, the Company had repurchased a total of **1,258,250 shares** for **$22.4 million**, with **$25.0 million** available for future purchases[145](index=145&type=chunk) - No shares were repurchased under this program during the three months ended June 30, 2021 and 2020[145](index=145&type=chunk) [Item 6. Exhibits](index=29&type=section&id=Item%206%20Exhibits) This section lists the exhibits filed as part of the Form 10-Q, including certifications under the Sarbanes-Oxley Act and various XBRL taxonomy extension documents - Key exhibits include certifications by G. Janelle Frost and Neal A. Fuller pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002[146](index=146&type=chunk) - The filing also includes various Inline XBRL Taxonomy Extension documents (Schema, Calculation Linkbase, Label Linkbase, Presentation Linkbase, Definition Linkbase) and the Cover Page Interactive Data File[144](index=144&type=chunk)[146](index=146&type=chunk) [SIGNATURES](index=30&type=section&id=SIGNATURES) This section contains the official signatures of the company's executive officers, certifying the accuracy of the report - The report was duly signed on behalf of AMERISAFE, INC. by G. Janelle Frost, President, Chief Executive Officer and Director, and Neal A. Fuller, Executive Vice President and Chief Financial Officer, on July 30, 2021[148](index=148&type=chunk)[149](index=149&type=chunk) ```
AMERISAFE(AMSF) - 2021 Q1 - Earnings Call Transcript
2021-05-01 11:32
AMERISAFE, Inc. (NASDAQ:AMSF) Q1 2021 Earnings Conference Call April 30, 2021 10:30 AM ET Company Participants Vincent Gagliano - EVP and Chief Risk Officer Janelle Frost - President and Chief Executive Officer Neal Fuller - Chief Financial Officer Conference Call Participants Matt Carletti - JMP Securities Mark Hughes - Truist Securities Randy Binner - B. Riley Securities Operator Good day, everyone, and welcome to the AMERISAFE 2021 First Quarter Earnings Conference Call. [Operator Instruction] At this ti ...
AMERISAFE(AMSF) - 2021 Q1 - Quarterly Report
2021-04-29 16:00
[Forward-Looking Statements](index=3&type=section&id=FORWARD-LOOKING%20STATEMENTS) This section outlines potential risks and uncertainties that could cause actual results to differ materially from anticipated results - Key factors include the impact of COVID-19, increased competition, changes in economic conditions, and greater than expected frequency or severity of claims[9](index=9&type=chunk) [Part I - Financial Information](index=4&type=section&id=PART%20I%20-%20FINANCIAL%20INFORMATION) This part presents the company's unaudited consolidated financial statements and management's discussion and analysis for the period [Item 1. Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited consolidated financial statements for AMERISAFE, Inc. as of March 31, 2021, including balance sheets, income statements, cash flows, and notes [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) This section provides the consolidated balance sheets, highlighting increases in total assets, liabilities, and shareholders' equity Consolidated Balance Sheet Highlights (in thousands) | Metric | March 31, 2021 | December 31, 2020 | | :--- | :--- | :--- | | **Total Investments** | $1,125,134 | $1,088,744 | | **Total Assets** | $1,494,579 | $1,470,855 | | **Total Liabilities** | $1,046,953 | $1,032,039 | | **Total Shareholders' Equity** | $447,626 | $438,816 | [Consolidated Statements of Income](index=5&type=section&id=Consolidated%20Statements%20of%20Income) This section presents the consolidated statements of income, showing a significant increase in net income for Q1 2021 Q1 2021 vs Q1 2020 Income Statement (in thousands, except per share data) | Metric | Q1 2021 | Q1 2020 | | :--- | :--- | :--- | | Gross Premiums Written | $81,514 | $87,071 | | Net Premiums Earned | $70,746 | $78,990 | | Total Revenues | $83,351 | $79,169 | | Total Expenses | $59,726 | $65,928 | | **Net Income** | **$19,312** | **$10,800** | | **Diluted EPS** | **$0.99** | **$0.56** | | Cash Dividends per Share | $0.29 | $0.27 | - **Net income increased significantly to $19.3 million** in Q1 2021 from **$10.8 million** in Q1 2020, primarily driven by net unrealized gains on equity securities of **$5.5 million** compared to a loss of **$8.8 million** in the prior year period[16](index=16&type=chunk) [Consolidated Statements of Cash Flows](index=8&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) This section details the consolidated statements of cash flows, showing changes in operating, investing, and financing activities Q1 2021 vs Q1 2020 Cash Flow Summary (in thousands) | Cash Flow Activity | Q1 2021 | Q1 2020 | | :--- | :--- | :--- | | Net Cash from Operating Activities | $16,593 | $15,212 | | Net Cash (Used in) / Provided by Investing Activities | ($39,601) | $25,755 | | Net Cash Used in Financing Activities | ($5,675) | ($5,257) | | **Change in Cash and Cash Equivalents** | **($28,683)** | **$35,710** | [Note 4. Investments](index=10&type=section&id=Note%204.%20Investments) This note provides details on the company's investment portfolio, primarily composed of fixed maturity securities Investment Portfolio Summary as of March 31, 2021 (in thousands) | Investment Category | Carrying Amount / Fair Value | | :--- | :--- | | **Held-to-Maturity (Amortized Cost)** | $575,108 | | **Available-for-Sale (Fair Value)** | $411,904 | | **Equity Securities (Fair Value)** | $50,843 | | **Total Investments (excluding short-term)** | $1,037,855 | - The investment portfolio is primarily composed of fixed maturity securities, with a significant allocation to states and political subdivisions. As of March 31, 2021, the company held **29 available-for-sale securities** in an unrealized loss position, none for longer than 12 months[39](index=39&type=chunk)[42](index=42&type=chunk)[53](index=53&type=chunk) [Note 6. Loss Reserves](index=14&type=section&id=Note%206.%20Loss%20Reserves) This note details the company's loss reserves and the impact of favorable prior accident year development - The company experienced favorable development of prior accident years' loss reserves, which reduced loss and loss adjustment expenses by **$11.4 million** in Q1 2021, compared to a **$13.6 million** reduction in Q1 2020[67](index=67&type=chunk) Reconciliation of Loss and Loss Adjustment Expenses (in thousands) | Description | Q1 2021 | Q1 2020 | | :--- | :--- | :--- | | Net Balance, Beginning of Period | $654,854 | $677,544 | | Incurred - Current Accident Year | $50,937 | $57,268 | | Incurred - Prior Accident Years | ($11,420) | ($13,621) | | Paid - Total | ($45,281) | ($46,874) | | **Net Balance, End of Period** | **$649,090** | **$674,317** | [Note 8. Fair Value Measurements](index=16&type=section&id=Note%208.%20Fair%20Value%20Measurements) This note describes the fair value measurement hierarchy for financial instruments, totaling $462.7 million in recurring assets - The company's financial instruments are measured at fair value using a three-level hierarchy. As of March 31, 2021, assets measured at fair value on a recurring basis totaled **$462.7 million**[75](index=75&type=chunk)[83](index=83&type=chunk) Fair Value of Recurring Measurement Assets as of March 31, 2021 (in thousands) | Input Level | Amount | | :--- | :--- | | Level 1 (Quoted Prices) | $86,849 | | Level 2 (Observable Inputs) | $375,898 | | Level 3 (Unobservable Inputs) | $0 | | **Total** | **$462,747** | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=20&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the financial condition and operating results for Q1 2021, highlighting premium trends and investment performance [Business Overview](index=20&type=section&id=Business%20Overview) This section outlines AMERISAFE's business model, focusing on workers' compensation insurance for hazardous industries - AMERISAFE specializes in providing workers' compensation insurance to small and mid-sized employers in hazardous industries such as construction, trucking, and manufacturing. The business strategy focuses on disciplined underwriting, proactive safety reviews, and intensive claims management[97](index=97&type=chunk) [Results of Operations](index=21&type=section&id=Results%20of%20Operations) This section analyzes key operational metrics, including gross premiums written, net investment income, and performance ratios - **Gross premiums written decreased by 6.4% to $81.5 million** in Q1 2021, primarily due to a **$3.3 million decrease** in premiums from payroll audits and a **$2.4 million decrease** in new voluntary policy premiums[102](index=102&type=chunk) - **Net investment income decreased 15.0% to $6.6 million**, attributed to lower investment yields on fixed income securities and cash balances[104](index=104&type=chunk) Key Performance Ratios | Metric | Q1 2021 | Q1 2020 | | :--- | :--- | :--- | | Net Combined Ratio | 84.6% | 83.5% | | Return on Average Equity | 17.4% | 10.0% | | Book Value per Share | $23.16 | $22.64 | [Liquidity and Capital Resources](index=22&type=section&id=Liquidity%20and%20Capital%20Resources) This section discusses the company's cash flow from operating and investing activities and overall capital management - **Net cash from operating activities increased to $16.6 million** in Q1 2021 from **$15.2 million** in Q1 2020, mainly due to lower underwriting expenses and losses paid[110](index=110&type=chunk) - The company experienced a significant shift in investing activities, with **net cash used of $39.6 million** in Q1 2021 compared to **net cash provided of $25.8 million** in Q1 2020, reflecting different patterns of investment purchases and sales/maturities[111](index=111&type=chunk) [Investment Portfolio](index=22&type=section&id=Investment%20Portfolio) This section details the composition of the company's investment portfolio as of March 31, 2021 Investment Portfolio Composition as of March 31, 2021 | Asset Class | Carrying Amount (in thousands) | Percentage of Portfolio | | :--- | :--- | :--- | | Fixed Maturity - Held-to-Maturity | $575,108 | 49.7% | | Fixed Maturity - Available-for-Sale | $411,904 | 35.5% | | Equity Securities | $50,843 | 4.4% | | Short-term Investments | $87,279 | 7.5% | | Cash and Cash Equivalents | $33,074 | 2.9% | | **Total** | **$1,158,208** | **100.0%** | [Prior Year Development](index=23&type=section&id=Prior%20Year%20Development) This section explains the favorable development of prior accident year loss reserves and its impact on expenses - The company recorded favorable prior accident year development of **$11.4 million** in Q1 2021, compared to **$13.6 million** in Q1 2020, largely due to favorable case reserve development from closed claims and claims where workers reached maximum medical improvement[117](index=117&type=chunk)[120](index=120&type=chunk) Favorable Prior Year Development by Accident Year (in millions) | Accident Year | Q1 2021 | Q1 2020 | | :--- | :--- | :--- | | 2018 | $4.5 | $0.0 | | 2017 | $2.5 | $2.9 | | 2016 | $1.5 | $3.1 | | Prior to 2016 | $2.9 | $7.6 | | **Total Net Development** | **$11.4** | **$13.6** | [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=24&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section confirms no material changes in the company's market risk profile since the previous fiscal year-end - There have been no material changes in the quantitative or qualitative aspects of the company's market risk profile since December 31, 2020[123](index=123&type=chunk) [Item 4. Controls and Procedures](index=25&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls were effective and reported no material changes to internal control over financial reporting - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of the end of the reporting period[125](index=125&type=chunk) - No changes in internal control over financial reporting occurred during the quarter that have materially affected, or are reasonably likely to materially affect, these controls[127](index=127&type=chunk) [Part II - Other Information](index=26&type=section&id=PART%20II%20-%20OTHER%20INFORMATION) This part includes information on unregistered sales of equity securities and a list of exhibits filed with the report [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=26&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details the company's share repurchase program, noting no repurchases in Q1 2021 and remaining authorization - The company did not repurchase any shares in the three months ended March 31, 2021[135](index=135&type=chunk) - As of March 31, 2021, **$25.0 million** remained available for future purchases under the company's share repurchase program[135](index=135&type=chunk) [Item 6. Exhibits](index=26&type=section&id=Item%206.%20Exhibits) This section lists the exhibits accompanying the Form 10-Q, including required CEO and CFO certifications - Exhibits filed include certifications from the CEO (G. Janelle Frost) and CFO (Neal A. Fuller) pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002[129](index=129&type=chunk)[130](index=130&type=chunk)[131](index=131&type=chunk)
AMERISAFE(AMSF) - 2020 Q4 - Earnings Call Transcript
2021-02-28 04:17
AMERISAFE, Inc. (NASDAQ:AMSF) Q4 2020 Earnings Conference Call February 25, 2021 10:30 AM ET Company Participants Kathryn Shirley - Chief Administrative Officer Janelle Frost - President and Chief Executive Officer Neal Fuller - Chief Financial Officer Conference Call Participants Matt Carletti - JMP Securities Mark Hughes - Truist Securities Randy Binner - B. Riley Securities Operator Good day, everyone and welcome to the AMERISAFE 2020 Fourth Quarter and Full Year Earnings Conference Call. Today’s confere ...
AMERISAFE(AMSF) - 2020 Q3 - Earnings Call Transcript
2020-10-31 17:27
AMERISAFE, Inc. (NASDAQ:AMSF) Q3 2020 Earnings Conference Call October 29, 2020 10:30 AM ET Company Participants Kathryn Shirley - EVP, CAO, Secretary Janelle Frost - President, CEO Neal Fuller - EVP, CFO Conference Call Participants Mark Hughes - Truist Randy Binner - B. Riley Matt Carletti - JMP Securities Operator Good day, everyone, and welcome to the AMERISAFE 2020 Third Quarter Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Kat ...
AMERISAFE(AMSF) - 2020 Q3 - Quarterly Report
2020-10-30 20:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-12251 AMERISAFE, INC. (Exact Name of Registrant as Specified in Its Charter) Texas 75-2069407 (State of Incorporation) (I.R.S. Employer ...